Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/110239
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHaidari, H.-
dc.contributor.authorZhang, Q.-
dc.contributor.authorMelville, E.-
dc.contributor.authorKopecki, Z.-
dc.contributor.authorSong, Y.-
dc.contributor.authorCowin, A.-
dc.contributor.authorGarg, S.-
dc.date.issued2017-
dc.identifier.citationJournal of Pharmaceutical Sciences, 2017; 106(7):1795-1804-
dc.identifier.issn0022-3549-
dc.identifier.issn1520-6017-
dc.identifier.urihttp://hdl.handle.net/2440/110239-
dc.description.abstractFlightless I (Flii) is an actin remodeling protein important for cytoskeletal regulation and cellular processes including migration, proliferation, and adhesion. Previous studies have clearly identified Flii as a novel therapeutical target for improved wound repair and have demonstrated Flii regulation using Flii neutralizing antibodies (FnAb) in different models of wound healing in vivo. Here we describe the development of an optimized topical delivery system that can neutralize Flii activity in the epidermis. Topical delivery of FnAb is an attractive approach as it provides a convenient application, sustained release, localized effect, and reduced dosage. Three successful formulations were developed, and their physical and chemical stability examined. The in vitro release revealed prolonged and sustained release of FnAb in all the tested formulations. Additionally, penetration studies using intact porcine skin showed that FnAb penetrated the epidermis and upper papillary dermis. The penetrated FnAb significantly reduced Flii expression compared to dosed matched IgG controls. This study has successfully developed a topical delivery system for FnAb that could serve as a potential platform for future localized wound treatments.-
dc.description.statementofresponsibilityHanif Haidari, Qian Zhang, Elizabeth Melville, Zlatko Kopecki, Yunmei Song, Allison J. Cowin, Sanjay Garg-
dc.language.isoen-
dc.publisherElsevier-
dc.rights© 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.-
dc.subjectTransdermal drug delivery; protein delivery; permeability; invitro models; wound healing-
dc.titleDevelopment of topical delivery systems for flightless neutralizing antibody-
dc.typeJournal article-
dc.identifier.doi10.1016/j.xphs.2017.03.012-
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/1102617-
pubs.publication-statusPublished-
dc.identifier.orcidKopecki, Z. [0000-0002-8072-4222]-
dc.identifier.orcidCowin, A. [0000-0003-2885-2080]-
Appears in Collections:Aurora harvest 3
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.